[Current trends in the treatment of patients with cranio-cerebral injuries. Personal experiences, with special reference to the prevention and therapy of gastrointestinal hemorrhages and to treatment with L-dopa].
D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology; D001930:Brain Injuries / Q000150:complications / Q000628:therapy*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007511:Ischemia / Q000150:complications; D007980:Levodopa / Q000627:therapeutic use*; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D012774:Shock, Traumatic / Q000150:complications / Q000517:prevention & control; D014812:Vitamin K / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014812:Vitamin K; D007980:Levodopa; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide
Attuali orientamenti nel trattamento del traumatizzato cranio-encefalico. La nostra esperienza, con particolare riferimento alla profilassi ed alla terapia delle emorragie gastroenteriche ed al trattamento con L-Dopa